首页>
外国专利>
Combined therapy with rammiditan and CGRP antagonist for use in migraine treatment
Combined therapy with rammiditan and CGRP antagonist for use in migraine treatment
展开▼
机译:与哺乳动物和CGRP拮抗剂用于偏头痛治疗的组合治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention is for the treatment of rasmiditane and calcitonin gene-related peptide (CGRP) antagonists, such as the combination of rasmiditane and galactanezumab, as well as migraine, especially migraine inappropriately controlled by lasmiditane or CGRP antagonist therapy alone. For more information on how to use that combination, the therapy resistance defined herein as migraine that is refractory to two or more conventional monotherapy and / or dual therapy treatment regimens. Regarding treating migraine.
展开▼